Medifast: Q3 Earnings Insights

Shares of Medifast (NYSE:MED) rose 9.75% in after-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share were up 120.45% over the past year to $2.91, which beat the estimate of $2.46.

Revenue of $271,470,000 up by 42.83% year over year, which beat the estimate of $240,620,000.

Outlook

Medifast hasn't issued any earnings guidance for the time being.

Revenue guidance hasn't been issued by the company for now.

Price Action

52-week high: $184.29

Company's 52-week low was at $49.03

Price action over last quarter: down 5.74%

Company Overview

Medifast Inc is a US-based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.